| Drug Type Biological products | 
| Synonyms Hemolox T, HML-110, HRC-102 | 
| Target | 
| Action modulators | 
| Mechanism Hemoglobins modulators | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseDiscontinuedDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Reperfusion Injury | Discovery | Canada  | - | 





